A Deep Learning-Based Radiomic Classifier for Usual Interstitial Pneumonia.

deep learning idiopathic pulmonary fibrosis interstitial lung disease progressive pulmonary fibrosis radiomic usual interstitial pneumonia

Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 18 07 2023
revised: 09 09 2023
accepted: 05 10 2023
medline: 10 2 2024
pubmed: 17 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

Because chest CT scan has largely supplanted surgical lung biopsy for diagnosing most cases of interstitial lung disease (ILD), tools to standardize CT scan interpretation are urgently needed. Does a deep learning (DL)-based classifier for usual interstitial pneumonia (UIP) derived using CT scan features accurately discriminate radiologist-determined visual UIP? A retrospective cohort study was performed. Chest CT scans acquired in individuals with and without ILD were drawn from a variety of public and private data sources. Using radiologist-determined visual UIP as ground truth, a convolutional neural network was used to learn discrete CT scan features of UIP, with outputs used to predict the likelihood of UIP using a linear support vector machine. Test performance characteristics were assessed in an independent performance cohort and multicenter ILD clinical cohort. Transplant-free survival was compared between UIP classification approaches using the Kaplan-Meier estimator and Cox proportional hazards regression. A total of 2,907 chest CT scans were included in the training (n = 1,934), validation (n = 408), and performance (n = 565) data sets. The prevalence of radiologist-determined visual UIP was 12.4% and 37.1% in the performance and ILD clinical cohorts, respectively. The DL-based UIP classifier predicted visual UIP in the performance cohort with sensitivity and specificity of 93% and 86%, respectively, and in the multicenter ILD clinical cohort with 81% and 77%, respectively. DL-based and visual UIP classification similarly discriminated survival, and outcomes were consistent among cases with positive DL-based UIP classification irrespective of visual classification. A DL-based classifier for UIP demonstrated good test performance across a wide range of UIP prevalence and similarly discriminated survival when compared with radiologist-determined UIP. This automated tool could efficiently screen for UIP in patients undergoing chest CT scan and identify a high-risk phenotype among those with known ILD.

Sections du résumé

BACKGROUND BACKGROUND
Because chest CT scan has largely supplanted surgical lung biopsy for diagnosing most cases of interstitial lung disease (ILD), tools to standardize CT scan interpretation are urgently needed.
RESEARCH QUESTION OBJECTIVE
Does a deep learning (DL)-based classifier for usual interstitial pneumonia (UIP) derived using CT scan features accurately discriminate radiologist-determined visual UIP?
STUDY DESIGN AND METHODS METHODS
A retrospective cohort study was performed. Chest CT scans acquired in individuals with and without ILD were drawn from a variety of public and private data sources. Using radiologist-determined visual UIP as ground truth, a convolutional neural network was used to learn discrete CT scan features of UIP, with outputs used to predict the likelihood of UIP using a linear support vector machine. Test performance characteristics were assessed in an independent performance cohort and multicenter ILD clinical cohort. Transplant-free survival was compared between UIP classification approaches using the Kaplan-Meier estimator and Cox proportional hazards regression.
RESULTS RESULTS
A total of 2,907 chest CT scans were included in the training (n = 1,934), validation (n = 408), and performance (n = 565) data sets. The prevalence of radiologist-determined visual UIP was 12.4% and 37.1% in the performance and ILD clinical cohorts, respectively. The DL-based UIP classifier predicted visual UIP in the performance cohort with sensitivity and specificity of 93% and 86%, respectively, and in the multicenter ILD clinical cohort with 81% and 77%, respectively. DL-based and visual UIP classification similarly discriminated survival, and outcomes were consistent among cases with positive DL-based UIP classification irrespective of visual classification.
INTERPRETATION CONCLUSIONS
A DL-based classifier for UIP demonstrated good test performance across a wide range of UIP prevalence and similarly discriminated survival when compared with radiologist-determined UIP. This automated tool could efficiently screen for UIP in patients undergoing chest CT scan and identify a high-risk phenotype among those with known ILD.

Identifiants

pubmed: 37844797
pii: S0012-3692(23)05569-1
doi: 10.1016/j.chest.2023.10.012
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

371-380

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL169166
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007749
Pays : United States

Informations de copyright

Copyright © 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: L. K., K. L., S. Z., and C. H. are employees of Imbio, Inc. H. G., E. S., S. L., and C. S. are paid consultants for Imbio, Inc. J. H. C., A. A., and J. M. O. report consulting fees from Genentech unrelated to this investigation. None declared (L. C., J. V. P., J. M. W., A. W. M., S. G., A. G.).

Auteurs

Jonathan H Chung (JH)

Department of Radiology, University of Chicago, Chicago, IL.

Lydia Chelala (L)

Department of Radiology, University of Chicago, Chicago, IL.

Janelle Vu Pugashetti (JV)

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI.

Jennifer M Wang (JM)

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI.

Ayodeji Adegunsoye (A)

Division of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL.

Alexander W Matyga (AW)

Department of Radiology, University of Chicago, Chicago, IL.

Lauren Keith (L)

Imbio, Inc, Minneapolis, MN.

Kai Ludwig (K)

Imbio, Inc, Minneapolis, MN.

Sahar Zafari (S)

Imbio, Inc, Minneapolis, MN.

Sahand Ghodrati (S)

Department of Radiology, University of California at Davis, Sacramento, CA.

Ahmadreza Ghasemiesfe (A)

Department of Radiology, University of California at Davis, Sacramento, CA.

Henry Guo (H)

Department of Radiology, Stanford University, Palo Alto, CA.

Eleanor Soo (E)

Heart and Lung Imaging, Ltd, London, England.

Stephen Lyen (S)

Heart and Lung Imaging, Ltd, London, England.

Charles Sayer (C)

Heart and Lung Imaging, Ltd, London, England.

Charles Hatt (C)

Imbio, Inc, Minneapolis, MN.

Justin M Oldham (JM)

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI; Department of Epidemiology, University of Michigan, Ann Arbor, MI. Electronic address: oldhamj@med.umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH